Singleron

Hagen, Germany Founded: 2018 • Age: 8 yrs
Developer of single-cell multi-omics platform for clinical research and molecular diagnosis

About Singleron

Singleron is a company based in Hagen (Germany) founded in 2018 by Jing Zhou and Nan Fang. Singleron has raised $84.48 million across 6 funding rounds from investors including Tencent, Arch Venture Partners and Lake Bleu Capital. Singleron has completed 1 acquisition, including Proteona. Singleron offers products and services including MobiuSCOPE Kit, PythoN iâ„¢, and Tensor System. Singleron operates in a competitive market with competitors including Arbor Biotechnologies, Mission Bio, Octant, Diagenode and Rebus Biosystems, among others.

  • Headquarter Hagen, Germany
  • Founders Jing Zhou, Nan Fang
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website singleron.bio
  • Social LinkedIn X
  • Legal Name Singleron Biotechnologies Gmbh
Key Metrics
  • Total Equity Funding
    $84.48M (USD)

    in 6 rounds

  • Investors
    Tencent

    & 14 more

  • Investments & Acquisitions

Products & Services of Singleron

Singleron offers a comprehensive portfolio of products and services, including MobiuSCOPE Kit, PythoN i™, and Tensor System.

MobiuSCOPE Kit
Sequencing Kit

Kit for full length single cell RNA sequencing applications

PythoN i™
Tissue Dissociation

System for intelligent tissue processing in single cell analysis

Tensor System
Processing System

Automated instrument for single cell library preparation

Funding Insights of Singleron

Singleron has successfully raised a total of $84.48M across 6 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $84.48M
  • Total Rounds 6
  • Investors Count 15

All 6 funding rounds of Singleron with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Nov 2021–Series B–Lake Bleu Capital, Firstred
Dec 2020$30MSeries A–Tencent
Nov 2020$10MSeries A––
Sep 2020$30MSeries A–Lilly Asia Ventures
–
Jun 2019$14.48MSeed–Sherpa Venture Capital, Yuanhe Holdings
–
May 2018–Seed–Yuanhe Holdings, Frees Fund
–
Valuation history

15 investors in total: 15 institutional.

Investors in Singleron

Singleron has secured backing from 15 investors, including venture fund and institutional investors. Prominent investors backing the company include Tencent, Arch Venture Partners and Lake Bleu Capital.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
-
–lakebleu-cap.com-
-
–sherpahp.com-
Private equity fund focused on multiple sectors
–cdginv.comWan Chai, China
Venture capital firm focused on life science companies
1986archventure.comChicago, United States
China-based startups are invested in by SBCVC across diverse sectors.
–sbcvc.comShanghai, China
Private equity and private debt firm focused on multiple sectors
–cdhfund.comKowloon, China
Investment firm focused on global life sciences and healthcare.
–superstringcap.comNew York, United States
Tech companies are invested in by MSA venture capital fund.
–msacap.comChaoyang, China
-
–sherpavc.com.cn-
Tech focused VC firm investing in early stage companies in the US & China
–freesvc.comBeijing, China
Premium access

Investor details for Singleron

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Singleron

19 people are tracked at Singleron (11 in leadership, 8 in team).

NameRoleGroup
Jing Zhou
Co-FounderLeadership
Nan Fang
Co-Founder & CEOLeadership
Bruno Monschau
Managing DirectorLeadership
Jonathan Scolnick
Managing DirectorLeadership
Andreas Schmidt
Phd; Svp, Head Of Global BDLeadership
Khalil Abou-El-Ardat
Senior Director Of Application SupportLeadership
Long Zhang
Senior Vice PresidentLeadership
Jue Fan
Phd; Svp, Global Head Of Bioinformatics And Data ScienceLeadership
Yifeng Gao
CFOLeadership
Julie Laliberte
General Manager/ Sr Director Of R&dLeadership
Yingting Wang
Senior Director Of Investor Relationship & MarketingLeadership
Rahel Oeser
Pr-managerTeam
Salih Yilmaz
Application ScientistTeam
Deniz Sinar
Bioinformatics ScientistTeam
Fei Sun
MD Phd; Dean, Nantong University, ChinaTeam
Joges Lew
Research And Development Team LeadTeam
Divya Lakshmi Damodaran
Senior Application SpecialistTeam
Verdiana Steccanella
Sr. Lab Manager - Library Prep Team LeaderTeam
Wayne Shiong
InvestorTeam
Premium access

Complete people profiles for Singleron

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Singleron

Singleron has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Proteona.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Single cell proteogenomics-based therapeutics are developed and provided.
proteona.comSingapore2016Mar 2022••••
Premium access

Complete acquisition details for Singleron

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Singleron

4 dated milestones of Singleron across 4 years, from founding to its latest funding, stage changes and deals.

  1. Founded Singleron is founded.
  2. Funding First funding round.
  3. Funding Latest funding round, Series B,.
  4. Acquisition Acquires Proteona.

Competitors of Singleron

Singleron operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Arbor Biotechnologies, Mission Bio, Octant, Diagenode and Rebus Biosystems, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
arbor.bio2016Cambridge, United States$304.1M117
Genomic technologies and drug discovery platforms are provided.
missionbio.com2014San Francisco, United States$110M109
Single-cell multi-omics platform is provided for genotypic and phenotypic analysis.
octant.bio2017Los Angeles, United States$110M63
Human cell interaction platform is provided for drug discovery.
diagenode.com2003Seraing, Belgium$8.45M99
Reagents and kits for epigenetics sequencing solutions are developed.
rebusbio.com2006Santa Clara, United States$20M–
An imaging system for single-cell gene analysis is developed.
zafrens.com2021San Diego, United States$29.16M19
Provider of single-cell multi-omics analysis platform for researchers
bionautlabs.com2015Los Angeles, United States$63.2M–
Miniature robots are developed for targeted drug delivery applications.
Premium access

Detailed competitors of Singleron

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Singleron

The website of Singleron (singleron.bio) receives about 6.6K visits a month.

  • Monthly visits
    6.6K

    ▼ 5.6% vs previous month

Latest news on Singleron

Similar companies to Singleron

10 companies that operate in the same segment as Singleron (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
mRNA-based therapeutics for diseases including cancer and infections are developed.
2010Cambridge, Massachusetts, United StatesUSD 2.78 BUSD 1.94 B5,800
Digital sequencing technology for cancer detection is developed.
2012Redwood City, California, United StatesUSD 557.5 MUSD 982.02 M2,020
Circulating tumor DNA is screened for early cancer detection.
2016Menlo Park, California, United StatesUSD 3.22 BUSD 147.17 M1,000
Nanopore-based electronic systems for single-molecule analysis are developed.
2005Oxford, Oxfordshire, United KingdomUSD 1.3 BUSD 301.49 M1,480
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits
2006Sunnyvale, California, United StatesUSD 943.53 MUSD 189.9 M265
Provider of DNA testing services to create a family tree and ancestor
2003Yehud, Central District, IsraelUSD 40 M––
Genetically modified cell lines are developed using AAV gene-editing platform.
2007Cambridge, Cambridgeshire, United KingdomUSD 46.29 M––
Gene therapies for rare diseases including retinal dystrophies are developed.
2013Philadelphia, Pennsylvania, United StatesUSD 82.8 MUSD 64.73 M822
Therapeutics for genetic diseases are developed through targeted interventions.
2015Palo Alto, California, United StatesUSD 434.2 MUSD 502.08 M730
Provider of an online genealogy platform offering a host of services
1996Lehi, Utah, United StatesUSD 146.2 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Singleron

Singleron was founded in 2018.

Singleron is headquartered in Hagen, Germany. It is registered at Hagen, North Rhine-westphalia, Germany.

Nan Fang is the current CEO of Singleron. They have also founded this company.

Singleron is a funded company, having raised a total of $84.48M across 6 funding rounds to date.

Singleron was founded in 2018 and is based in Hagen, Germany. Operations are centered in the biotechnology sector, where single-cell multi-omics platforms are provided for clinical research and molecular diagnosis. A product portfolio is offered, including instruments, microfluidic devices, reagents, software analysis tools, and database solutions to enable high-throughput single-cell analysis. Single-cell sequencing services are also delivered.

Singleron's top competitors include Arbor Biotechnologies, Mission Bio and Zafrens.

Singleron offers MobiuSCOPE Kit, PythoN iâ„¢, and Tensor System.

Singleron has made 1 acquisition, including Proteona.

Singleron has 15 investors. Key investors include Tencent, Arch Venture Partners, Lake Bleu Capital, Firstred, and Sherpa Healthcare Partners.

Singleron operates through Singleron Biotechnologies Gmbh.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available